search

All clinical trials

Results 465511-465520 of 470744

Metabolomics and Microbiomics in Cardiovascular Diseases

Acute Heart FailureNSTEMI - Non-ST Segment Elevation MI7 more

"MEtabolomics and MicrObiomics in caRdIovAscular diseases Mannheim (MEMORIAM) " is a single-center, prospective and observational study investigating to identify disease-specific metabolic, respectively microbiomic, patterns of patients with high-risk cardiovascular diseases. High-risk cardiovascular diseases comprise patients suffering from acute heart failure (AHF), ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI), sepsis, septic shock, ischemic and non-ischemic cardiomyopathy.

Unknown status7 enrollment criteria

Utilizing Technology for Optimization of Pain Management and Mobilization in High Risk Cardiac Surgical...

Transplant; FailureHeart3 more

The purpose of this project is to improve mobility in the perioperative period using activity trackers to augment current practice. Delirium and poor functional status following ICU stays are intractable problems for which clear solutions do not exist. Digital health approaches have not been applied to these problems in the ICU setting and may represent a viable and unexplored intervention. The program will involve the utilization of an activity tracker in ambulating patients. There will be two arms to the program. The first will involve the longitudinal study of ambulating lung transplant patients. Patients will be given an activity tracker at time of transplant which will continue throughout their care into their first month at home. The data will be collected to identify correlation between activity and clinical outcomes.

Unknown status11 enrollment criteria

Patterns of Injury and Mortality in Free-fall Trauma Patients

Trauma

In this study, the investigator aimed to analyze the demographic characteristics, patterns of injury and mortality after free fall in a Taiwan level one trauma center.

Unknown status2 enrollment criteria

A Pilot Study to Explore the Role of Gut Flora in Elevated Cholesterol

CholesterolElevated1 more

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding Elevated Cholesterol.

Unknown status11 enrollment criteria

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Migraine Headaches

Migraine

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.

Unknown status9 enrollment criteria

Ultrasound and Functional Thyroid Evaluation

ThyroidGland; Functional Disturbance

Thyroid disorders are most commonly concomitant with prematurity and still remains a controversial topic. The incidence of a temporary form of hypothyroidism among preterm neonates is higher than in the general population. Transient prematurity hypothyroxinemia is defined as a temporary reduction in FT4 values without increase in TSH values. Currently, there is no consensus about normal thyrotropine (TSH) and free thyroxine (FT4) values in preterm infants. The aim of this study is to determine the volume of the thyroid gland in preterm infants born between 24 and 32 weeks of gestation inborn or admitted to the unit within 14 days from birth and compare it with the results of TSH and FT4 blood concentration. Besides, the objective of the study is to determine values of thyroid hormones in premature infants born before 33 wk gestation to help neonatologist to interpreter the thyroid hormone results

Unknown status11 enrollment criteria

Breathing Pattern, WOB and Gas Exchange in Patients With Acute Respiratory Distress Syndrome During...

Work of BreathingARDS1 more

There is little evidence about the mechanical characteristics and muscular function in patients with Acute Respiratory Distress Syndrome (ARDS) at the time of weaning of the mechanical ventilation, as well as the behavior of the mechanical properties, breathing pattern, muscular effort, and gas exchange during a successful and failed spontaneous breathing trial.

Unknown status9 enrollment criteria

Early Origins of Allergy and Asthma

AllergyAsthma3 more

Birth cohort study with recruitment during pregnancy to determine prenatal and perinatal conditions, as well as genetic and epigenetic factors, that participate in the early setting of immune responses, and the role of these in the later determination of the risk of allergic diseases, asthma, and metabolic conditions in the offspring.

Unknown status3 enrollment criteria

Pattern and Management of Intracranial Cavernoma

Management of Intracranial Cavernous Hemangioma

Intracranial cavernous vascular malformations are variously known as cavernous angiomas, cavernous hemangiomas, or, more simply, cavernomas. Cavernomas are congenital low flow vascular lesions. It composed of irregular sinusoidal vascular channels, lacking smooth muscle, and elastic fibers. They lack feeding arteries or draining veins and contain no neural tissue. The first description of an intracranial cavernoma was given by Virchow, in 1863. For over a century, it was considered to be an extremely rare malformation, usually found at autopsy, and exceptionally diagnosed during life. The prevalence of cerebral cavernous malformations (CCM) is estimated to be 0.4-0.9%.

Unknown status3 enrollment criteria

Evaluate the Improving Effects of Visucomplex Plus on Quality of Life in Patients With AMD

AMD

This is an observational study in which patients affected by dry or wet AMD will be enrolled, after signing the Informed Consent, according to eligibility criteria. Patients, after signing the Informed Consent, will enter into a screening phase during which the concomitant medication, clinical history, physical examination (including smoking habits) will be checked and the inclusion/exclusion criteria will be assessed. Then, at the time of Baseline visit (V0) the eligible patients will be given Visucomplex Plus as monotherapy, 1 capsule daily after food, or for dry or wet AMD patients under treatment with a stable dose of an anti-VEGF drug, Visucomplex Plus, 1 capsule daily after food, upon physical decision. Screening phase and the baseline visit (V0) could coincide.

Unknown status17 enrollment criteria
1...465514655246553...47075

Need Help? Contact our team!


We'll reach out to this number within 24 hrs